InvestorsHub Logo
Followers 0
Posts 350
Boards Moderated 0
Alias Born 05/08/2015

Re: 136 post# 7776

Thursday, 04/07/2016 5:56:24 PM

Thursday, April 07, 2016 5:56:24 PM

Post# of 18666
I've got it since fall 2015 and no it wont expand to include "much much more patients", it maxes out at 29 patients for the combined trials and the Phase I trials had a success rate of 4% so they have some serious work to do jacking that success rate up to make it out of Phase II...and you're missing phase III then drug approval, so about 4-5 years from now this product could potentially become FDA approved at a success rate below 9%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News